RUNX1 Research Program

@runx1-fpd.org

We are the only foundation in the world dedicated to supporting individuals with a rare blood disorder called RUNX1 Familial Platelet Disorder (RUNX1-FPD). We fund research and provide resources to improve the lives of those affected by this condition.

Don’t miss our next #MedEd webinar “Hereditary Hematologic Malignancies: Not That Rare” featuring Dr. Kelly Bolton (Washington University School of Medicine). • Wednesday, October 1 • 12:30 PM PT Expert Q&A Panelists: • Dr. Sravanti Rangaraju • Kelcy Smith-Simmer, MMSc, CGC Register today:

Bild

Increasing participation in blood cancer trials is essential for advancing treatment, yet many patients face barriers. Dr. Gwen Nichols shares how @llsusa.bsky.social's Equity in Access Research Program works to remove them. LOIs due Sept 11, 2025: runx1researchprogram.org/bLLSEquityBlog

RUNX1 Research Program

Learn how LLS’s Equity in Access Research Program addresses barriers to blood cancer clinical trials, improving access for underrepresented patients.

runx1researchprogram.org

🎗️ Today is National Cancer Survivors Day 🎗️ Today we honor the strength, resilience, and hope of everyone affected by cancer: those newly diagnosed, those in treatment, those in remission, and the families, caregivers, and loved ones supporting them.

Bild

ATTN #RUNX1 Clinicians: RRP offers specialized resources, peer groups, educational events & research opportunities specifically for RUNX1-FPD patients. Please refer your patients directly to Amanda Eggen (aeggen@runx1-fpd.org) & share our site: runx1-fpd.org.

Bild